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Abstract
Isothermal nucleic acid amplification is a simple process that rapidly and efficiently accu-
mulates nucleic acid sequences at constant temperature such as 37 and 42°C. Isothermal 
nucleic acid amplification approach offers several advantages over temperature circle 
methods (such as PCR) including rapid assay results, cost-effectiveness, and portabil-
ity. Two detection approaches based on circular strand-displacement polymerization 
reaction (CSDPR) were presented in this chapter for sensitive and specific thalassemia 
gene detection. One is a lateral flow strip biosensor based on CSDPR for semi-quanti-
tative detection of thalassemia DNA. The other is a spectrophotometric DNA detection 
approach based on CSDPR for quantitative detection of thalassemia DNA.
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1. Introduction
Thalassemia is a heterogeneous group of inherited disorders characterized by the reduced 
synthesis of one or more normal hemoglobin chains leading to imbalanced globin chain 
synthesis, which results in microcytic anemia [1–3]. Based on genetic disorders, thalassemia 
is divided into two main types, alpha-thalassemia and beta-thalassemia. Alpha- and beta-
thalassemia occur when there is a reduction in alpha-globin chains and beta-globin chains, 
respectively. Symptom of anemia is variable ranging from none to severe.
Because the structural hemoglobin variants and thalassemias occur at high frequencies in 
some populations, both types of genetic defect can be found in the same individual such as 
-SEA/-α3.7. The different genetic varieties of thalassemia and their combinations with genes for 
abnormal hemoglobins produce a series of disorders defined as thalassemia syndromes [4].
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Until now, marrow transplantation is the only way in which they can be cured. Unfortunately, 
expensive fee and restricted marrow sources have hindered its application in thalassemia 
patients. Therefore, thalassemia carrier screening in premarital checkup is an effective way for 
defective child birth. Carrier screening for thalassemia can reduce the burden on individuals 
by identifying those at increased risk, thereby enabling individuals to receive information 
about their health, future health, and/or potential health of their offspring, so that they are 
informed and understand their reproductive risks and options [5].
Traditional diagnosis methods include osmotic fragility test and hemoglobin electrophoresis 
techniques. The decrease of osmotic fragility indicates the decrease of hemoglobin produc-
tion. Although it is simple and convenient, osmotic fragility test is not specific for thalassemia. 
Hemoglobin electrophoresis was used to initially identify samples for common hemoglobin-
pathies such S and C. More complex electrophoresis techniques were then used to identify 
a great number of hemoglobin subtypes. Nevertheless, electrophoresis techniques are very 
complicated in experimental procedures, low in sensitivity, and difficult for quantitation.
Along with the advances in molecular biology, a variety of novel nucleic acid detection meth-
ods have been invented and applied in thalassemia gene detection, such as gap-PCR [6], 
reverse dot blot (RDB) [7], and DNA microarray [8]. However, these methods for thalassemia 
detection rely solely on PCR to amplify target genes. They are not only expensive and com-
plicated in procedure, but also liable to contamination. On the other hand, as they operate at 
a constant temperature (mostly at 37°C), the isothermal nucleic acid amplification approach 
offers several advantages over temperature circle methods including rapid assay results, cost-
effectiveness, and portability.
2. Emerging techniques for thalassemia gene detection
2.1. Types of globin
Globin, the protein portion of the hemoglobin molecule, is a tetramer consisted of two α and 
two non-α-globin chains. The structure and ontogeny of the hemoglobins are listed in Figure 1. 
The α-globin chains are encoded by two closely linked genes (α2 and α1) located on chromo-
some 16. The non-α genes, β, γ, and δ, are encoded by a cluster of genes on chromosome 11. 
All types of hemoglobins have similar protein structures. Each hemoglobin has a quaternary 
structure composed of two separate pairs of the same globin chains. The embryonic hemoglo-
bins consists of two ζ or α chains and two ε or γ chains; all normal human hemoglobins consist 
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There are two main classes of thalassemia, and, in which α- and β-globin genes are involved. 
Table 1 summarizes the different classes of α/β-thalassemia mutations. When only 1 of the 4 
α-globin chain genes is defective, the patient has little clinical symptoms and this silent con-
dition can only be detected at birth by the presence of a small amount of Bart hemoglobin. 
Thalassemia and Other Hemolytic Anemias30
α hemoglobin is made up of 4 γ-globin chains. Current high performance liquid chromatog-
raphy (HPLC) techniques are relatively insensitive to the very low level of Bart hemoglobin 
with a single chain defect and are, therefore, not useful for the diagnosis of α-thalassemia car-
riers. Heterozygous α0 and homozygous α+ patients show microcytosis, hypochromia, and a 
Figure 1. Schematic illustration for genetic control and protein structures of hemoglobin. The α- and β-globin are 
controlled by gene clusters located on chromosomes 11 and 16, respectively. Each hemoglobin has a quaternary structure 
composed of two separate pairs of the same globin chains.
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Table 1. Classes of mutations that cause α/β-thalassemia.
Emerging Techniques for Thalassemia Gene Detection
http://dx.doi.org/10.5772/intechopen.75695
31
mild anemia, suggesting thalassemia minor. Patients with β-thalassemia minor due to either a 
gene deletion (β0) or mutation (β+) can be identified by the slight elevation in fetal hemoglobin 
and an increase in the hemoglobin A
2
 level to between 4 and 7%.
2.2. Detection of thalassemia genes with traditional methods
Carrier detection approaches must be able to detect α- and β-thalassemias. The results 
of complete blood cell count (CBC) including the values of MCH, MCV, HbA
2
, and HbF 
can provide clues to the hematological characteristics of the different types of thalassemia 
genes and their interactions. The most common thalassemia mutations and abnormal 
hemoglobins can be detected by PCR-based techniques such as RDB and gap-PCR. The 
main applications of molecular detection for carrier analysis are summarized as follows. 1. 
Heterozygous α-thalassemia and homozygous α-thalassemia can be discriminated by the 
analysis of α-thalassemia mutations using gap-PCR; 2. The identification of β-thalassemia 
mutations for patients requires prenatal diagnosis to predict the severity of the clinical 
phenotype of homozygous β-thalassemia; 3. The discrimination between δβ-thalassemia 
and hereditary persistence of fetal hemoglobin (HPFH) deletions can be carried out by 
gap-PCR [9].
Routine detection strategies for the detection of thalassemia gene are mainly based on 
PCR. Gap-PCR was developed for the detection of deletion types of thalassemia gene muta-
tions. More than eight β-thalassemia deletions and two common α+-thalassemia deletion 
genes, the -α3.7 and -α4.2 alleles, and five α0-thalassemia deletion genes, the three Southeast 
Asian deletions (-SEA, -THAI and -FIL) and two Mediterranean deletions (-MED and -α20.5), can be 
detected by gap-PCR.
Meanwhile, allele-specific oligonucleotide hybridization (ASO) and RDB are applied to non-
deletional α- and β-thalassemia mutations. ASO is used to detect single base mutations with-
out the need of PCR or gel electrophoresis. For mutation analysis, a panel of ASO probes is 
employed to detect mutations in patients. For prenatal diagnosis and for genotyping homo-
zygous patients, two labeled probes are employed to detect the mutation sequence, one com-
plimentary to the normal gene DNA sequence and the other complimentary to the mutant 
DNA sequence at the same position. Generally, there is only one nucleotide difference in the 
two ASO probes. The genotype of the sample is observed by the absence or presence of the 
hybridization signal of two ASO probes.
In the RDB assay, the amplified target DNA is first fixed to a nylon membrane to form a filter-
fixed DNA dot, the dot is then hybridized to ASO probes whose 5′ terminal was conjugated 
with either P-labeled deoxynucleoside triphosphates, biotin or horseradish peroxidase. The 
technique has been successfully applied in many laboratories, especially for populations with 
just one common mutation and a small number of rare ones. However, RDB was not suitable for 
the screening of a large number of different mutations because the method is time-consuming 
as it needs separate hybridization and washing steps for each mutation.
All these routine methods for thalassemia detection are tedious, expensive, and liable to con-
tamination. To improve these methods, many PCR-derived methods have been developed 
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and applied to thalassemia gene assay, such as real time PCR, dissociation curve analysis, and 
droplet digital PCR. These methods are simple; however, expensive apparatus and need for 
experienced personnel hinder their broad application in basic level laboratories.
Recently, many amplification strategies have been developed to improve the sensitivity of 
DNA detection. Two commonly used methods are target amplification and signal amplifica-
tion. PCR as well as several isothermal amplification techniques such as rolling circle ampli-
fication (RCA) and helicase-dependent amplification (HDA) are typical target amplification 
strategies. However, these conventional amplification methods for sequence-specific DNA 
detection suffer from the limitations of complicated procedures, easy contamination, and 
high cost, which have been hampering their application in many laboratories. Signal ampli-
fication techniques that are commonly applied to directly amplify the detection signal have 
been developed to overcome the disadvantages of traditional target amplification strategies. 
These amplification approaches including nicking enzyme signal amplification (NESA) and 
CSDPR [10], which are most commonly used for sequence-specific DNA amplification, pro-
vide several advantages over target amplification approaches including ease of use, portabil-
ity, rapid assay results, and cost-effectiveness. Particularly, CSDPR combined with different 
detection platforms have attracted great attention due to its robustness and simplicity. CSDPR 
amplifies the DNA signal at an isothermal temperature that yields a large amount of DNA 
signal products that can be detected with different platforms.
2.3.1. Detection thalassemia gene with emerging techniques lateral flow biosensors
Based on CSDPR and gold nanoparticles (AuNPs), we have developed a lateral flow biosen-
sor (LFB) for the visual detection of thalassemia genes [11]. This sensor is highly sensitive (the 
detection limit is 0.01 fM of nucleic acid), highly specific, and easy to use. It does not require 
the use of complex and expensive instrumentation. The development of this biosensor repre-
sents an important step toward point-of-care testing for genetic disorders. The Southeast Asia 
(SEA) deletion of α-thalassemia was detected with this lateral flow biosensor. The method has 
been successfully validated for the detection of the SEA type of α-thalassemia (100% concor-
dance with the results obtained using PCR). In addition, this test can distinguish SEA from 
other types of thalassemia, such as -α3.7, -α4.2, and β-thalassemia.
As depicted in Figure 2, a CSDPR reaction comprising biotin-modified hairpin DNA, digoxin-
modified primer, and DNA polymerase is initiated by target mutant DNA strand. The hairpin 
probe forms a stem-loop structure with biotin at the 5′ end of the stem region. The stem is 
a 10-nt sequence, and the loop is a 20-nt sequence that is complementary to the mutant tar-
get DNA. The 8-nt primer includes a digoxin tag at the 5′ end and is complementary to the 
stem region of the probe at the 3′ end. The biotin-modified hairpin recognizes and hybridizes 
with SEA mutant DNA when present, causing the hairpin probe to undergo a conformational 
change that leads to stem separation (1). The primer then anneals with the open stem (2) and 
triggers a polymerization reaction in the presence of dNTPs and polymerase Klenow exo- (3). 
During primer extension, the mutant DNA is displaced by the strand displacement activity of 
the polymerase, permitting the synthesis of complementary DNA and formation of a hairpin-
DNA complex. To start the next cycle, the displaced target mutant DNA strand hybridizes with 
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another hairpin probe, initiating another round of polymerization (4). Through this cyclical 
process, a large number of tagged-duplex DNA complexes are produced from a minute amount 
of target mutant DNA. The hairpin retains its original stem-loop structure in the presence of 
Figure 2. Illustration of the production of sequence tagged duplex DNA based on CSDPR and the structure of a lateral 
flow biosensor including four steps. (1) the biotin-modified hairpin recognizes and hybridizes with SEA mutant DNA 
when present, causing the hairpin probe to undergo stem and loop separation; (2) the primer then anneals with the open 
stem; (3) this triggers a polymerization reaction in the presence of dNTPs and polymerase Klenow exo-; (4) to start the 
next cycle, the displaced target mutant DNA strand hybridizes with another hairpin probe.
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wild-type or non-complementary DNA due to the weak hybridization between wild-type DNA 
and the hairpin probe. Therefore, the primer is unable to anneal to the hairpin to induce a 
polymerization reaction, and no tagged-duplex DNA complex is produced.
The large number of tagged-duplex DNA complexes produced by the CSDPR reaction is then 
detected using an LFB. As shown in Figure 2, the CSDPR products are mixed with a run-
ning buffer and migrate along the LFB by capillary action to the conjugate pad, where anti-
digoxin–AuNP conjugates are deposited. The digoxin attached to the duplex DNA reacts with 
anti-digoxin on the AuNP surface to form a complex that consists of biotin-double strand 
DNA-digoxin–anti-digoxin–AuNP. The resulting complexes can be arrested by streptavidin 
at the test zone. The accumulation of gold nanoparticles on the test zone can be observed as 
an obvious red band. Superfluous free anti-digoxin-AuNP complexes keep on moving and 
accumulate at the control zone to form a second red band. In the absence of mutant SEA 
DNA or in the presence of wild-type DNA or non-complementary DNA, no duplex DNA is 
produced in the CSDPR; therefore, no anti-digoxin-AuNP conjugate is captured, and no red 
band is observed at the test zone. In this case, the observation of a red band at the control zone 
indicates that the LFB is working correctly.
This assay termed as lateral flow nucleic acid biosensor (LFNAB) can reach a sensitivity of 
0.01 fM when using synthetic target DNA. Figure 3 presents typical images together with 
the corresponding optical responses of the biosensors when loaded with various amounts of 
synthetic target DNA.
2.3.2. Spectrophotometric approach
LFNAB can qualitatively detect DNA by naked eye without expensive apparatus. It is fast 
and convenient. However, LFNAB is a qualitative or semi-quantitative detection method and 
the color observation may vary between different people. Therefore, we have developed a 
spectrophotometric DNA detection approach based on CSDPR for sensitive, selective, inex-
pensive, and quantitative detection of South East Asia (SEA) type of α-thalassemia [12]. As 
depicted in Figure 4, the signal amplification system is composed of a hairpin capture probe, 
a primer, polymerase, and streptavidin-horse radish peroxidase (SA-HRP). The structure of 
the hairpin capture probe consists of a biotin at 3′ end, a 11 base pair (bp) stem, a thiol group 
at 5′ end, and a 20-nt loop. The sequence of the loop is complementary to the target DNA. The 
primer (8-nt) is complementary to the stem region of the hairpin probe at 3′ end. The hairpin 
probe was first fixed on a gold nanoparticles (AuNPs) layer, which is coated by γ-globulin on 
a 96-well microtiter plate.
In the presence of target DNA, the loop region of the hairpin probe recognizes and hybridizes 
with the target DNA, causing conformational change of the hairpin probe to open the stem of 
the hairpin. The short primer then hybridizes with the open stem sequence and triggers a polym-
erization reaction in the presence of polymerase and dNTPs. Along with primer extension, the 
target DNA is released by polymerase with strand displacement activity, after which a longer 
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complementary DNA is produced, forming a hairpin–DNA complex. The displaced target can 
hybridize with another immobilized hairpin probe to start the next cycle, which triggers yet 
another polymerization and target DNA release. Through this cyclical process, a great num-
ber of duplex DNA complexes with the biotin labeled are produced. The biotin groups on the 
duplex DNA products can conjugate with the SA-HRP. Finally, the target DNA can be sensi-
tively detected via the HRP catalyzed substrate 3, 3′, 5, 5′-tetramethylbenzidine using a microtiter 
plate reader.
When the target DNA was absent or non-complementary DNA (such as wild-type DNA) 
was present, the fixed hairpin probe keeps the stem-loop structure and the reaction of biotin–
SA-HRP would not take place as the steric effect. No signal would be detected.
Under optimal conditions, the sensitivity was calculated to be 8 aM and the dynamic range of 
the assay was from 0.1 fM to 10 nM. Figure 5 presents the absorption spectrum and calibration 
curve of the assay.
Figure 3. (A) Typical photographic images (left) and corresponding intensities (right) of an LFNAB in the presence of 
various concentrations of synthetic target DNA and the negative control. (B) Photographic images (left) and corresponding 
intensities (right) of the LFNAB tested with target DNA and target DNA including one or more mismatched bases. 
(C) Calibration curve of an LFNAB with various concentrations of target DNA. The error bars represent the standard 
deviations, n = 3.
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CSDPR is a promising method for the detection of thalassemia genes. When combined 
with nucleic acid point-of-care testing methods such as DNA strip and spectrophotometric 
 biosensors, this isothermal DNA amplification based approach could be widely applied in 
thalassemia carrier screening, especially in community hospitals.
Figure 4. Schematic illustration for DNA detection based on CSDPR.
Figure 5. (A) Absorption spectrum response of the assay with different target DNA (0, 0.01 fM, 0.1 fM, 10 fM, 1 pM, 100 
pM, 10 nM and 1 μM). (B) Calibration curve of the DNA assay with different concentrations of target DNA. Standard 
deviation was represent as error bars, n = 3.




Lingwen Zeng1,2*, Luxin Yu3 and Yinghui Zhang2
*Address all correspondence to: zeng6@yahoo.com
1 Institute of Environment and Safety, Wuhan Academy of Agricultural Sciences, Wuhan, 
China
2 School of Food Science and Engineering, Foshan University, Foshan, China
3 Guangdong Medical University, Dongguan, Guangdong, China
References
[1] Ingram VM, Stretton AO. Genetic basis of the thalassemia diseases. Nature. 1959;184: 
1903-1909
[2] Higgs DR, Vickers MA, Wilkie AO, Pretorius IM, Jarman AP, Weatherall DJA. Review of 
the molecular genetics of the human alpha-globin gene cluster. Blood. 1989;73(5):1081-1104
[3] Weatherall DJ. Phenotype-genotype relationships in monogenic disease: Lessons from 
the thalassemias. Nature Reviews. Genetics. 2001;2(4):245-255. DOI: 10.1038/35066048
[4] Weatherall DJ, Clegg JB. The Thalassemia Syndromes. 4th ed. Blackwell: Oxford; 2001
[5] Cousens NE, Gaff CL, Metcalfe SA, Delatycki MB. Carrier screening for beta-thalassemia: 
A review of international practice. European Journal of Human Genetics. 2010;18(10):1077-
1083. DOI: 10.1038/ejhg.2010.90
[6] Chang JG, Lee LS, Lin CP, Chen PH, Chen CP. Rapid diagnosis of alpha-thalassemia-1 
of Southeast Asia type and hydrops fetalis by polymerase chain reaction. Blood. 
1991;78(3):853-854
[7] Saiki RK, Walsh PS, Levenson CH, Erlich HA. Genetic analysis of amplified DNA with 
immobilized sequence-specific oligonucleotide probes. Proceedings of the National 
Academy of Sciences of the United States of America. 1989;86(16):6230-6234
[8] Bang-Ce Y, Hongqiong L, Zhuanfong Z, Zhengsong L, Jianling G. Simultaneous detection 
of alpha-thalassemia and beta-thalassemia by oligonucleotide microarray. Haematologica. 
2004;89(8):1010-1012
[9] Old JM. Screening and genetic diagnosis of haemoglobin disorders. Blood Reviews. 
2003;17(1):43-53
[10] Guo Q, Yang X, Wang K, Tan W, Li W, Tang H, Li H. Sensitive fluorescence detection of 
nucleic acids based on isothermal circular strand-displacement polymerization reaction. 
Nucleic Acids Research. 2009;37(3):e20. DOI: 10.1093/nar/gkn1024
Thalassemia and Other Hemolytic Anemias38
[11] Yu L, Wu W, Lie P, Liu Y, Zeng L. Isothermal strand-displacement polymerase reaction 
for visual detection of the Southeast Asian–type deletion of α-thalassemia. The Journal 
of Molecular Diagnostics. 2013;15(6):766-782. DOI: 10.1016/j.jmoldx.2013.06.003
[12] Yu L, Wu W, Chen J, Xiao Z, Ge C, Lie P, Fang Z, Chen L, Zhang Y, Zeng L. Spectrophotometric 
and ultrasensitive DNA bioassay by circular-strand displacement polymerization reac-
tion. The Analyst. 2013;138(23):7182-7187. DOI: 10.1039/c3an01347b
Emerging Techniques for Thalassemia Gene Detection
http://dx.doi.org/10.5772/intechopen.75695
39

